Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP523663.RAW7qrARXWvq2WCA_2VHwVry4V72fyC6vtDlDLUcrYMds130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP523663.RAW7qrARXWvq2WCA_2VHwVry4V72fyC6vtDlDLUcrYMds130_assertion type Assertion NP523663.RAW7qrARXWvq2WCA_2VHwVry4V72fyC6vtDlDLUcrYMds130_head.
- NP523663.RAW7qrARXWvq2WCA_2VHwVry4V72fyC6vtDlDLUcrYMds130_assertion description "[Therefore, ST3 represents an appropriate target for specific MMP inhibitor(s) in future therapeutical approaches directed against the stromal compartment of human carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523663.RAW7qrARXWvq2WCA_2VHwVry4V72fyC6vtDlDLUcrYMds130_provenance.
- NP523663.RAW7qrARXWvq2WCA_2VHwVry4V72fyC6vtDlDLUcrYMds130_assertion evidence source_evidence_literature NP523663.RAW7qrARXWvq2WCA_2VHwVry4V72fyC6vtDlDLUcrYMds130_provenance.
- NP523663.RAW7qrARXWvq2WCA_2VHwVry4V72fyC6vtDlDLUcrYMds130_assertion SIO_000772 9508784 NP523663.RAW7qrARXWvq2WCA_2VHwVry4V72fyC6vtDlDLUcrYMds130_provenance.
- NP523663.RAW7qrARXWvq2WCA_2VHwVry4V72fyC6vtDlDLUcrYMds130_assertion wasDerivedFrom befree-20140225 NP523663.RAW7qrARXWvq2WCA_2VHwVry4V72fyC6vtDlDLUcrYMds130_provenance.
- NP523663.RAW7qrARXWvq2WCA_2VHwVry4V72fyC6vtDlDLUcrYMds130_assertion wasGeneratedBy ECO_0000203 NP523663.RAW7qrARXWvq2WCA_2VHwVry4V72fyC6vtDlDLUcrYMds130_provenance.